[Pharmacotherapy in bipolar disorder].
In the treatment of manic depressive disorders a distinction is made between acute treatment (combating the mania and the depression) and the maintenance treatment (prevention of subsequent episodes). In both forms of therapy the mood stabilizers are crucial: lithium carbonate, the anticonvulsants carbamazepine and valproic acid. The efficacy of lithium carbonate has been demonstrated in the acute treatment of mania and depression as well as in the maintenance treatment. Carbamazepine may be regarded as a good alternative, especially for the acute treatment of mania and for the maintenance treatment. Valproic acid so far has only be demonstrated to be efficacious in the acute treatment of mania. Monotherapy with a mood stabilizer is a first option, but its insufficient efficacy in many patients nevertheless necessitates a combined treatment, with two or even three mood stabilizers or with a mood stabilizer and other psychoactive agents. In the acute treatment of mania, antipsychotics are indicated in case of a severe or psychotic mania and benzodiazepines in severe disorders of sleep or restlessness. Antidepressants have a role as comedication in the acute treatment of the bipolar depression.
Universitair Medisch Centrum Utrecht/H.C.Rümkegroep, Willem Arntsz Huis.
W A
WA
Nolen
D000208:Acute Disease; D000927:Anticonvulsants / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D016651:Lithium Carbonate / Q000627:therapeutic use*; D008297:Male; D055502:Secondary Prevention
D000927:Anticonvulsants; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D016651:Lithium Carbonate
Farmacotherapie bij de manisch-depressieve stoornis.